Kari alitalo biography of abraham

          VEGF-C and VEGF-D both stimulate the growth of lymphatic vessels, being the first growth factors found for lymphatic endothelial cells.

        1. Vascular endothelial growth factor C (VEGF-C) recently has been described to be a relatively specific growth factor for the lymphatic vascular system.
        2. In adults, lymphangiogenesis occurs physiologically during development of the corpus luteum and wound healing (Alitalo et al., , Otsuki et.
        3. We thank Drs. Ulrich Muller and Louis Reichardt, Reinhard Fässler, and Kari Alitalo for providing β1flox/flox, Tie1-Cre, and Tie1-GFP mice.
        4. Vascular endothelial growth factor (VEGF) has been shown to promote neovascularization in animal models and, more recently, in human subjects.

          5. In adults, lymphangiogenesis occurs physiologically during development of the corpus luteum and wound healing (Alitalo et al., , Otsuki et....

          Kari Alitalo

          Finnish MD and a medical researcher

          Kari Kustaa Alitalo (born 21 May 1952 in Kuopio[1]) is a FinnishMD and a medical researcher.

          He is a foreign associated member of the National Academy of Sciences of the US.[2] He became famous for his discoveries of several receptor tyrosine kinases (RTKs)[3][4][5] and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C).[6] In the years 1996–2007 he was Europe's second most cited author in the field of cell biology.[7] Alitalo is currently serving as an Academy Professor for the Academy of Finland.[8]

          Alitalo received the Leopold Griffuel Prize in 2002[9] and the 2006 Louis-Jeantet Prize for Medicine.[10] He also received the 2005 Eric Fernström Foundation's Nordic Prize[11] and the 2009 In-Bev Baillet Latour Health Prize.[12] In 2014, he receiv